The Valley Desk

NCT00751738 · Interventional trial

Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs)

Overall registry status Completed

Phase 3

Conditions Arrhythmias

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov